Molina Healthcare (MOH) Receives a Buy from Bernstein

Bernstein analyst Lance Wilkes maintained a Buy rating on Molina Healthcare today and set a price target of $224.00.

Claim 50% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

According to TipRanks, Wilkes is a 2-star analyst with an average return of 0.8% and a 50.00% success rate. Wilkes covers the Healthcare sector, focusing on stocks such as CVS Health, Agilon Health, and Centene.

In addition to Bernstein, Molina Healthcare also received a Buy from TipRanks – OpenAI’s OpenAI Medical – Healthcare Plans in a report issued yesterday. However, today, Truist Financial maintained a Hold rating on Molina Healthcare (NYSE: MOH).

Based on Molina Healthcare’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $11.48 billion and a net profit of $79 million. In comparison, last year the company earned a revenue of $10.34 billion and had a net profit of $326 million

Based on the recent corporate insider activity of 64 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MOH in relation to earlier this year. Most recently, in November 2025, Schapiro Richard, a Director at MOH sold 357.00 shares for a total of $51,058.14.